| Literature DB >> 32140502 |
Anuradha Chandramohan1, Umar M Siddiqi1, Rohin Mittal2, Anu Eapen1, Mark R Jesudason2, Thomas S Ram3, Ashish Singh4, Dipti Masih5.
Abstract
PURPOSE: To assess the diagnostic performance, interobserver agreement and confidence level for determining response to neoadjuvant chemoradiotherapy (NACRT) using morphology based MR-tumour regression grade (MR TRG), diffusion weighted imaging (DWI) patterns and their combination in patients with locally advanced rectal cancer.Entities:
Keywords: AJCC, American Joint Committee on Cancer; AUC, area under the curve; Complete response; DWI, diffusion weighted imaging; Diffusion weighted imaging; IR, incomplete response; LCCRT, neoadjuvant long course chemoradiotherapy; MERCURY, Magnetic Resonance Imaging and Rectal Cancer European Equivalence Study; MR, TRG MR-tumour regression grade; MRI; NACRT, neoadjuvant chemoradiotherapy; Neoadjuvant chemotherapy; Rectal cancer; T2-HR MRI, T2 high resolution MRI; cCR, clinical complete response; p-TRG, pathological tumour regression grade; pCR, pathological complete response
Year: 2020 PMID: 32140502 PMCID: PMC7044654 DOI: 10.1016/j.ejro.2020.100223
Source DB: PubMed Journal: Eur J Radiol Open ISSN: 2352-0477
Fig. 1Consort flow chart showing patients included in the study.
MRI imaging protocol used in 3T and 1.5T scanners for both T2 high resolution (T2-HR) MRI and diffusion weighted imaging (DWI).
| Scan parameters | Intera 22 Achieva 3.0 T | Magnetom Avanto fit, 1.5T | ||
|---|---|---|---|---|
| T2-HR | DWI | T2-HR | DWI | |
| Repetition Time | 3500 | 3750 | 4000 | 3000 |
| Echo time | 90 | 75 | 105 | 61 |
| Slice thickness (mm) | 3 | 5 | 3 | 5 |
| FOV (cm) | 20 | 25 | 18 - 20 | 22 |
| Matrix | 368 × 290 | 128 × 116 | 325 × 250 | 128 × 116 |
| Sensitivity encoding factor | 2-2.5 | 1.7 | 2 | 1.9 |
| Echo train length | 25 | 1 | 12 | 1 |
| No. of signal averages | 2-6 | 4-6 | 2-6 | 4-6 |
| No. of slices | 20-40 | 20-30 | 20-40 | 20-30 |
| Acquisition time (minutes) | 3-4 | 3-4 | 4-6 | 5 |
| B-values | – | 0, 400, 800 | – | 0, 400, 800 |
| Echo planar imaging factor | – | 77 | – | 108 |
| Fat suppression technique | – | SPAIR | – | SPAIR |
Criteria for response assessment on post neoadjuvant chemoradiotherapy (NACRT) MRI using T2-high resolution (T2-HR) MRI based MR-TRG by MERCURY study group [7], diffusion weighted imaging (DWI) patterns and their combination.
| MR-TRG | T2-HR MRI | DWI | Combination of T2 HR and DWI |
|---|---|---|---|
| 1 | Normal rectal wall or thin band of fibrosis | No foci of restricted diffusion | T2 HR 1/2/3 + DWI 1 |
| 2 | Thick band of fibrosis with doubtful residual tumor | Few scattered foci of restricted diffusion | T2 HR 2/3 + DWI 2 |
| 3 | Fibrosis/ mucin > 50 % with tumor | C-shaped band or nodular focus of restricted diffusion | T2 HR 2/3 + DWI 3 |
| 4 | Little fibrosis, mostly tumour | Smaller than pre-Rx MR | T2 HR 4 + DWI 4 |
| 5 | No response or progression | No change since previous | T2 HR 5 + DWI 5 |
MERCURY - Magnetic Resonance Imaging and Rectal Cancer European Equivalence Study (7).
Fig. 2Restaging MRI of six different patients with pathological complete response show the spectrum of appearances of complete response on T2 HR images and DWI. (A–C) In three different patients who had features of complete response on both T2 HR images and DWI, there was with thin hypointense band of fibrosis in patient 1(A) and patient 2(B) and there was normalisation of rectal wall in patient 3(C). All three patients had no restricted diffusion on DWI. (D–F) MRI of three different patients who had features of complete response on DWI (dwi-TRG-1), but were either called as mrTRG-2 (D,E) due to thick band of fibrosis or mrTRG-3 (F) due to thick band of predominant fibrosis interspersed by intermediate signal areas on T2 HR images.
Fig. 3Restaging MRI of two different patients with pathological incomplete response (pTRG-2). (A,B) Patient 1 was called as complete response based on T2 HR image (mr-TRG1), but DWI showed few scattered foci of restricted diffusion suggestive of incomplete response (dwi-TRG-2). (C,D) Patient 2 had thick band of fibrosis on T2 HR images (mr-TRG-2) and the DWI showed few scattered foci of restricted diffusion suggestive of dwi-TRG 2.
Fig. 4Restaging MRI of three different patients with incomplete response (pTRG-3). (A) Patient 1 showed thick band of fibrosis (mr-TRG-2) on T2 HR images and DWI showed a C-shaped restricted diffusion along the left wall of the rectum suggestive of dwi-TRG-3. (B) Patient 2 had greater than 50 % fibrosis with intermediate signal intensity areas along the left wall of rectum (mrTRG-3). DWI showed a nodular focus of restricted diffusion suggestive of dwi-TRG-3. (C) Patient 3 had less than 50 % tumor signal areas than fibrosis on T2 HR images and was called mr-TRG-4. DWI showed curvilinear C shaped focus of restricted diffusion from 4-10 O’clock suggestive of dwi-TRG3.
Comparison of patient and tumor characteristics between pathological complete (pCR) and incomplete responders (pIR).
| Characteristics Total N = 251 | Pathological complete response (pCR) N = 37 | Pathological incomplete response (pIR) N = 214 | p-value |
|---|---|---|---|
| Age | 47.7 +/-12.1 years | 48.3+/-14.3 years | 0.301 |
| (22–70 years) | (19–86 years) | ||
| Male: Female | 26:11 | 138:76 | 0.495 |
| Pre-treatment biopsy: | 0.584 | ||
| Well to moderately differentiated | 8 (21.6 %) | 48 (22.4 %) | |
| Moderately differentiated | 24 (64.8 %) | 147 (68.6 %) | |
| Poorly differentiated | 5 (13.5 % | 19 (8.7 %) | |
| Length of tumor | 4.6 +/- 1.8 cm (1.8–10.6 cm) | 5.3 +/-1.9 cm (2–14 cm) | 0.066 |
| Location | <0.001 | ||
| Low/ low mid | 26 (70.2 %) | 92 (42.9 %) | |
| Mid/ mid high | 9 (24.4 %) | 59 (27.5 %) | |
| High | 2 (5.4 %) | 42 (19.6 %) | |
| Long segment | – | 21 (9.8 %) | |
| Annular | 17 (45.9 %) | 124 (57.9 %) | 0.174 |
| Semi-annular | 20 (54.1 %) | 90 (42.1 %) | |
| Intermediate signal intensity | 32 (86.5 %) | 181 (84.6 %) | 0.949 |
| Hyperintense | 2 (5.4 %) | 14 (6.5 %) | |
| Mixed signal intensity | 3 (8.1 %) | 19 (8.9 %) | |
| 0.237 | |||
| 22 (59.5 %) | 130 (60.7 %) | ||
| 11 (29.6 %) | 49 (22.9 %) | ||
| 4 (10.8 %) | 8 (3.7 %) | ||
| 0 | 27 (12.6 %) | ||
| T-stage on pretreatment staging MRI: | 0.211 | ||
| mrT2 | 5 (13.5 %) | 17 (8 %) | |
| mrT3 | 26 (70.3 %) | 147 (68.7 %) | |
| mrT4 | 6 (16.2 %) | 50 (23.4 %) | |
| mrN0 | 24 (64.9 %) | 72 (33.6 %) | 0.001 |
| mrN1 | 6 (16.2 %) | 97 (45.3 %) | |
| mrN2 | 7 (18.9 %)) | 45 (21.0 %) | |
| CRM =0 mm | 24 (64.9 %) | 135 (63.1 %) | 0.467 |
| EMVI positive | 7 (18.9 %) | 81 (37.9 %) | 0.003 |
| Pelvic sidewall disease | 3 (8.1 %) | 18 (8.4 %) | 0.951 |
| y-mrT-stage: | ymrT0 = 30 (30/251 = 11.9 %) | ||
| ymrT1/2 = 101/251 (40.2 %) | |||
| ymrT3 = 86/251 (34.2 %) | |||
| ymrT4 = 34/251 (13.5 %) | |||
| y-mrN -stage | y-mr- N0 = 167 (66.5 %) | ||
| y-mr- N1 = 71 (28.3) | |||
| y-mr- N2 = 13 (5.2 %) | |||
| y-pT-stage | ypT0 = 37(14.7 %) | ||
| ypTis = 5 (2%) | |||
| ypT1/T2 = 84 (33.5 %) | |||
| ypT3 = 113 (45 %) | |||
| ypT4 = 12 (4.8 %) | |||
| y-pN-stage | pN0 = 175 (69.7 %) | ||
| pN1 = 57 (22.7 %) | |||
| pN2 = 19 (7.6 %) | |||
Comparison between the reference standard and the response assessment using T2 high resolution MRI, diffusion weighted imaging and their combination.
| MR-TRG | T2-HR MRI | DWI | Combination of T2 HR and DWI | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Observer 1 | Observer 2 | Observer 1 | Observer 2 | Observer 1 | Observer 2 | |||||||
| pCR N = 37 | pIR N = 214 | pCR N = 37 | pIR N = 214 | pCR N = 37 | pIR N = 214 | pCR N = 37 | pIR N = 214 | pCR N = 37 | pIR N = 214 | pCR N = 37 | pIR N = 214 | |
| 1 | 3 | 4 | 5 | 4 | 30 | 8 | 12 | 4 | 28 | 2 | 14 | 5 |
| 2 | 24 | 26 | 13 | 12 | 6 | 72 | 10 | 38 | 6 | 52 | 6 | 19 |
| 3 | 8 | 94 | 10 | 93 | 0 | 61 | 7 | 90 | 1 | 78 | 6 | 75 |
| 4 | 2 | 77 | 9 | 101 | 1 | 61 | 8 | 77 | 2 | 70 | 11 | 109 |
| 5 | 0 | 13 | 0 | 4 | 0 | 12 | 0 | 4 | 0 | 12 | 0 | 4 |
Diagnostic performance of response assessment using T2 high resolution MRI, diffusion weighted imaging and their combination.
| Observer 1 | Observer 2 | |||||
|---|---|---|---|---|---|---|
| T2HR | DWI | T2+DWI | T2HR | DWI | T2+DWI | |
| CR | 7 | 38 | 30 | 9 | 16 | 19 |
| IR | 244 | 213 | 221 | 242 | 235 | 232 |
| Sensitivity | 8.1 | 81.1 | 75.6 | 13.5 | 32.4 | 37.8 |
| Specificity | 98.1 | 96.2 | 99 | 98.1 | 98.1 | 97.6 |
| PPV | 42.8 | 78.9 | 93.3 | 55.5 | 75 | 73.6 |
| NPV | 86 | 96.7 | 95.9 | 86.7 | 89.3 | 90 |
| Accuracy | 84.8 | 94 | 95.6 | 85.6 | 88.4 | 88.8 |
| AUC | 0.531 | 0.887 | 0.874 | 0.558 | 0.653 | 0.678 |
Mode of the level of confidence for each assessment category for both the observers combined. Likert’s scale used for the level of confidence is as follows: 5 - very confident, 4 - confident, 3 - not sure, 2 - less confident and 1 - not at all confident.
| MR-TRG | T2 HR MRI | DWI | T2 HR + DWI | |||
|---|---|---|---|---|---|---|
| Mode of the level of confidence | (N/TR) and % | Mode of the level of confidence | (N/TR) and % | Mode of the level of confidence | (N/TR) and % | |
| 4 | (10/16) 62.5 | 4 | (42/54) 77 | 5 | (39/49) 79.6 | |
| 1 | (52/75) 69.3 | 2 | (52/126) 41.2 | 4 | (51/83) 61.4 | |
| 2 | (63/205) 30.7 | 4 | (113/158) 71.5 | 5 | (106/160) 66.2 | |
| 5 | (153/189) 80.9 | 5 | (128/147) 87 | 5 | (143/192) 74.4 | |
| 5 | (15/17) 88.2 | 5 | (12/16) 75 | 5 | (15/16) 93.7 | |
*(N/TR) and %= number of responses for the mode of level of confidence divided by the total number of responses in that category for both observers combined and their percentage.